Turning Point Therapeutics’ $325 Million Common Stock Offering

Ambrogio Visconti

Cooley acted as counsel to Turning Point Therapeutics, while Davis Polk advised the joint book-running managers in connection with the offering. Turning Point Therapeutics, Inc. executed…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now